Bicycle Therapeutics (BCYC) PT Raised to $19 at Goldman Sachs
Tweet
Share
E-mailGet Alerts BCYC Hot Sheet
Price: $22.52 -0.66%
Rating Summary:
15 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
15 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Goldman Sachs analyst Graig Suvannavejh raised the price target on Bicycle Therapeutics (NASDAQ: BCYC) to $19.00 (from $17.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tyler Tech (TYL) PT Raised to $500 at Oppenheimer
- Teradyne (TER) PT Raised to $125 at TD Cowen
- Reliance Industries (RIL:IN) PT Raised to INR2,630 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
